Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Preterm~* Very low birth weight baby: birth weight 1-1.5 kg~* Both inside and outside delivered babies~* Gender: males and females~* Probable severe sepsis (septic score)~Exclusion Criteria:~* Extremely low birth weight babies: \< 1 kg~* Babies \>1.5 kg birth weight~* Babies born with congenital malformations~* Full term babies~* IUGR babies~* Child with no signs of sepsis~* HBsAg Positive~* HIV Positive

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 30 Days
- Healthy Volunteers: f

Study Arms:
- case group (Type: ACTIVE_COMPARATOR): 'IgM rich immunoglobulin' intravenous infusion in the dose of 5 ml/ kg/ dose over 3 hours once a day for 3 days.
- control group (Type: PLACEBO_COMPARATOR): antibiotics only

Based on this trial design, predict the completion outcome and termination type (if applicable).